ArticleCellular oncology (Dordrecht, Netherlands)2019

CDK7 inhibition as a promising therapeutic strategy for lung squamous cell carcinomas with a SOX2 amplification.

Jae Young Hur et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.